Drug Type Small molecule drug |
Synonyms Kerledex |
Action inhibitors, antagonists |
Mechanism NCC inhibitors(Thiazide-sensitive sodium-chloride cotransporter inhibitors), adrenergic receptor antagonists(Adrenergic receptors antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseWithdrawn |
First Approval Date United States (30 Oct 1992), |
Regulation- |
Molecular FormulaC14H11ClN2O4S |
InChIKeyJIVPVXMEBJLZRO-UHFFFAOYSA-N |
CAS Registry77-36-1 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |





